The invention relates to the use of mesenchymal stem cells (MSCs) for treating systemic inflammatory response syndrome (SIRS) in a subject. The invention provides compositions, uses and methods for the treatment of SIRS.
申请公布号
CA2732908(A1)
申请公布日期
2010.02.11
申请号
CA20092732908
申请日期
2009.08.03
申请人
CELLERIX SA;CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
